Charani Ranasinghe
Department of Immunology,
John Curtin School of Medical Research,
Department of Immunology, John Curtin School of Medical Research
Australian National University
Charani Ranasinghe has not added Biography.
If you are Charani Ranasinghe and would like to personalize this page please email our Author Liaison for assistance.
Matrix assisted laser desorption ionisation time of flight mass spectrometry (MALDI-TOF MS) for detecting novel Bt toxins.
Journal of invertebrate pathology Jan, 2002 | Pubmed ID: 12054787
Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use.
Vaccine Sep, 2005 | Pubmed ID: 15964105
Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Vaccine Oct, 2005 | Pubmed ID: 15985317
Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.
Vaccine Jul, 2006 | Pubmed ID: 16759767
Prime-boost strategies in DNA vaccines.
Methods in molecular medicine , 2006 | Pubmed ID: 16988455
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
Vaccine Nov, 2006 | Pubmed ID: 17050052
Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles.
Journal of immunology (Baltimore, Md. : 1950) Feb, 2007 | Pubmed ID: 17277143
Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2008 | Pubmed ID: 18490714
Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity.
European journal of immunology Jul, 2009 | Pubmed ID: 19582753
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.
Expert review of vaccines Sep, 2009 | Pubmed ID: 19722891
Human immunodeficiency virus-1 vaccine design: where do we go now?
Immunology and cell biology Mar, 2011 | Pubmed ID: 20956986
Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
Immunology and cell biology Aug, 2011 | Pubmed ID: 21173782
A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.
Vaccine Apr, 2011 | Pubmed ID: 21352941
Role of novel type I interferon epsilon in viral infection and mucosal immunity.
Mucosal immunology Nov, 2012 | Pubmed ID: 22617838
Fluorescent target array killing assay: a multiplex cytotoxic T-cell assay to measure detailed T-cell antigen specificity and avidity in vivo.
Cytometry. Part A : the journal of the International Society for Analytical Cytology Aug, 2012 | Pubmed ID: 22740235
Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
Journal of immunological methods Jan, 2013 | Pubmed ID: 23123200
Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity.
PloS one , 2013 | Pubmed ID: 23383283
CCR6 is transiently upregulated on B cells after activation and modulates the germinal center reaction in the mouse.
Immunology and cell biology May, 2013 | Pubmed ID: 23588497
IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8⁺ T cell avidity following HIV-1 recombinant pox viral vaccination.
Vaccine Sep, 2013 | Pubmed ID: 23933364
New advances in mucosal vaccination.
Immunology letters Jan, 2014 | Pubmed ID: 24462961
Progresses in DNA-based heterologous prime-boost immunization strategies.
Methods in molecular biology (Clifton, N.J.) , 2014 | Pubmed ID: 24715282
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유